First Known Report of


Journal

International journal of environmental research and public health
ISSN: 1660-4601
Titre abrégé: Int J Environ Res Public Health
Pays: Switzerland
ID NLM: 101238455

Informations de publication

Date de publication:
14 03 2023
Historique:
received: 25 01 2023
revised: 14 02 2023
accepted: 17 02 2023
medline: 30 3 2023
entrez: 29 3 2023
pubmed: 30 3 2023
Statut: epublish

Résumé

Colistin is a last-resort antibiotic used to treat infections caused by multidrug-resistant Gram-negative bacteria. People with a history of travel to the Dominican Republic have become sick with pathogenic bacteria carrying the mobile colistin resistance gene,

Identifiants

pubmed: 36982034
pii: ijerph20065123
doi: 10.3390/ijerph20065123
pmc: PMC10049167
pii:
doi:

Substances chimiques

Colistin Z67X93HJG1
Anti-Bacterial Agents 0
Escherichia coli Proteins 0
MCR-1 protein, E coli 0

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Références

BMC Bioinformatics. 2010 Dec 10;11:595
pubmed: 21143983
mBio. 2019 May 7;10(3):
pubmed: 31064835
Front Microbiol. 2019 Oct 10;10:2267
pubmed: 31681191
Front Cell Infect Microbiol. 2021 Nov 25;11:771510
pubmed: 34900756
Lett Appl Microbiol. 2022 Aug;75(2):224-233
pubmed: 35388505
Trop Med Infect Dis. 2019 Jan 29;4(1):
pubmed: 30700019
Infect Drug Resist. 2019 Aug 27;12:2649-2653
pubmed: 31695440
Front Microbiol. 2019 Dec 12;10:2824
pubmed: 31921017
Front Microbiol. 2020 Jan 17;10:3072
pubmed: 32010114
Front Microbiol. 2018 Nov 05;9:2659
pubmed: 30455680
Acta Vet Scand. 2017 May 19;59(1):31
pubmed: 28526080
Am J Public Health. 2015 Dec;105(12):2409-10
pubmed: 26469675
Lancet Infect Dis. 2016 Feb;16(2):144-5
pubmed: 26711363
Emerg Microbes Infect. 2020 Dec;9(1):508-516
pubmed: 32116151
PLoS One. 2015 Mar 23;10(3):e0120761
pubmed: 25798951
Lancet Infect Dis. 2019 Dec;19(12):1325-1335
pubmed: 31653524
Infect Drug Resist. 2019 Jul 16;12:2135-2149
pubmed: 31410033
Ann N Y Acad Sci. 2019 Apr;1441(1):8-16
pubmed: 30924540
Emerg Infect Dis. 2017 Dec;23(12):2023-2029
pubmed: 29148380
Front Microbiol. 2018 Jun 12;9:1217
pubmed: 29951045
Sci Rep. 2017 Nov 10;7(1):15364
pubmed: 29127343
Front Microbiol. 2016 Nov 11;7:1789
pubmed: 27891118
Sci Rep. 2017 Mar 24;7(1):424
pubmed: 28336940
Sci Rep. 2018 Feb 27;8(1):3705
pubmed: 29487327
Lancet Infect Dis. 2016 Feb;16(2):161-8
pubmed: 26603172
Microbiol Resour Announc. 2022 May 19;11(5):e0011822
pubmed: 35416692

Auteurs

Angela Perdomo (A)

School of Veterinary Medicine, Texas Tech University, Amarillo, TX 79409, USA.

Hattie E Webb (HE)

Division of Foodborne, Waterborne, and Environmental Diseases, Centers for Disease Control and Prevention, Atlanta, GA 30329, USA.

Marie Bugarel (M)

Division of Research and Development Resources, BioMérieux, 69795 Lyon, France.

Cindy R Friedman (CR)

Division of Global Migration and Quarantine, Centers for Disease Control and Prevention, Atlanta, GA 30329, USA.

Louise K Francois Watkins (LK)

Division of Foodborne, Waterborne, and Environmental Diseases, Centers for Disease Control and Prevention, Atlanta, GA 30329, USA.

Guy H Loneragan (GH)

School of Veterinary Medicine, Texas Tech University, Amarillo, TX 79409, USA.

Alexandra Calle (A)

School of Veterinary Medicine, Texas Tech University, Amarillo, TX 79409, USA.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH